Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: updated evidence report and systematic review for the US Preventive …
Importance Pathogenic mutations in breast cancer susceptibility
genesBRCA1andBRCA2increase risks for breast, ovarian, fallopian tube, and peritoneal …
genesBRCA1andBRCA2increase risks for breast, ovarian, fallopian tube, and peritoneal …
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the US Preventive Services Task Force …
HD Nelson, M Pappas, B Zakher… - Annals of internal …, 2014 - acpjournals.org
Background: Mutations in breast cancer susceptibility genes (BRCA1 and BRCA2) are
associated with increased risks for breast, ovarian, and other types of cancer. Purpose: To …
associated with increased risks for breast, ovarian, and other types of cancer. Purpose: To …
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: systematic review to update the US Preventive Services Task Force …
HD Nelson, R Fu, K Goddard, JP Mitchell… - 2013 - pubmed.ncbi.nlm.nih.gov
Purpose To review new evidence on the benefits and harms of risk assessment, genetic
counseling, and genetic testing for BRCA-related cancer in women for the US Preventive …
counseling, and genetic testing for BRCA-related cancer in women for the US Preventive …
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US Preventive Services Task Force recommendation statement
DK Owens, KW Davidson, AH Krist, MJ Barry… - Jama, 2019 - jamanetwork.com
Importance Potentially harmful mutations of the breast cancer susceptibility 1 and 2 genes
(BRCA1/2) are associated with increased risk for breast, ovarian, fallopian tube, and …
(BRCA1/2) are associated with increased risk for breast, ovarian, fallopian tube, and …
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US Preventive Services Task Force recommendation statement
US Preventive Services Task Force - Obstetrical & Gynecological …, 2019 - journals.lww.com
For women in the United States, BRCA1/2 mutations occur in approximately 1 in 300 to 500
women. Risk of ovarian, fallopian, and peritoneal cancer is also increased to 39% in those …
women. Risk of ovarian, fallopian, and peritoneal cancer is also increased to 39% in those …
Identification and management of women with BRCA mutations or hereditary predisposition for breast and ovarian cancer
S Pruthi, BS Gostout, NM Lindor - Mayo Clinic Proceedings, 2010 - Elsevier
Women with a germline BRCA1 or BRCA2 mutation or a hereditary predisposition for breast
and ovarian cancer have substantial risk of breast or ovarian cancer relative to the general …
and ovarian cancer have substantial risk of breast or ovarian cancer relative to the general …
Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in BRCA1/2: A Review of Secondary Prevention Guidelines
B Dullens, R de Putter, M Lambertini, A Toss… - Journal of …, 2020 - Wiley Online Library
Germline pathogenic alterations in the breast cancer susceptibility genes 1 (BRCA1) and 2
(BRCA2) are the most prevalent causes of hereditary breast and ovarian cancer. The …
(BRCA2) are the most prevalent causes of hereditary breast and ovarian cancer. The …
Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review for the US Preventive Services Task …
Background: Clinically significant mutations of BRCA1 and BRCA2 genes are associated
with increased susceptibility for breast and ovarian cancer. Although these mutations are …
with increased susceptibility for breast and ovarian cancer. Although these mutations are …
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: US Preventive Services Task Force recommendation statement
VA Moyer… - Annals of internal …, 2014 - acpjournals.org
Description: Update of the 2005 US Preventive Services Task Force (USPSTF)
recommendation on genetic risk assessment and BRCA mutation testing for breast and …
recommendation on genetic risk assessment and BRCA mutation testing for breast and …
Expansion of cancer risk profile for BRCA1 and BRCA2 pathogenic variants
Y Momozawa, R Sasai, Y Usui, K Shiraishi… - JAMA …, 2022 - jamanetwork.com
Importance The clinical importance of genetic testing ofBRCA1andBRCA2in breast, ovarian,
prostate, and pancreatic cancers is widely recognized. However, there is insufficient …
prostate, and pancreatic cancers is widely recognized. However, there is insufficient …
相关搜索
- risk assessment genetic counseling
- task force genetic counseling
- risk assessment task force
- cancer in women genetic counseling
- cancer in women task force
- cancer in women risk assessment
- risk of breast ovarian cancer
- brca mutations ovarian cancer
- brca mutations management of women
- management of women ovarian cancer
- risk assessment genetic testing
- task force genetic testing
- cancer in women genetic testing
- task force ovarian cancer